Back to Journals » Drug Design, Development and Therapy » Volume 16

Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation [Retraction]

Authors Omar MM , Eleraky NE, El Sisi AM, Ali Hasan O

Received 13 July 2022

Accepted for publication 13 July 2022

Published 15 July 2022 Volume 2022:16 Pages 2291—2292


Omar MM, Eleraky NE, El Sisi AM, Ali Hasan O. Drug Des Devel Ther. 2019;13:4413–4430.

The Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. Concerns were raised regarding the alleged image manipulation of the TEM micrograph shown in Figure 2. It appears several of the small spherical vesicles shown in the figure are duplicates of each other.

The authors did not respond to our queries and the decision was made to retract the article. The authors were notified of this.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.